HPV E6 / E7 mRNA screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study
International Journal of Gynecology & Obstetrics · 2025-04 · 169 (1) · 215-223
DOI: 10.1002/ijgo.16043 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 25.11.2024. Verfasst von Ying Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Papillomavirus Infections, Oncogene Proteins, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Province medical health science and technology project, "Nursery" Scientific Research Program of Affiliated Hospital of Jining Medical University.
Abstract (Originalsprache)
Background
This study aimed to assess the value of a HPV E6/E7 mRNA assay (Aptima® HPV [AHPV]) for primary cervical cancer screening combined with menopausal status.
Methods
A total of 16 917 women underwent AHPV testing and had complete histopathological results at the Affiliated Hospital of Jining Medical University China between January 1, 2017 and March 31, 2022. We evaluated the performance of different screening strategies and combined strategies, as well as evaluations of different menopausal states.
Results
When identifying LSIL+ (includes low‐ and high‐grade squamous intraepithelial lesions and invasive cervical cancer [ICC]), the sensitivity (91.2%) and negative predictive value (NPV; 96.6%) were significantly higher for AHPV than for liquid‐based cytology assay (LBC; 33.2% and 84.7% for sensitivity and NPV, respectively). Furthermore, the co‐testing strategy (cytology combined with AHPV), when compared with AHPV, achieved a slightly higher sensitivity (93.6% vs. 91.2%, respectively, P < 0.001), a similar specificity (61.3% vs. 62.7%, respectively, P = 0.014), a similar positive predictive value (PPV; 37.5% vs. 37.8%, respectively, P = 0.709) and a similar NPV (97.5% vs. 96.6%, respectively, P = 0.001). Moreover, AHPV (when compared with menopausal women) achieved a higher sensitivity (93.5% vs. 77.7%, respectively, P < 0.001), a higher NPV (97.3% vs. 93.9%, respectively, P < 0.001), a similar PPV (37.8% vs. 37.0%, respectively, P = 0.618) and a slightly lower specificity (60.7% vs. 72.1%, respectively, P < 0.001) in premenopausal women. These results were similar when identifying HSIL+ (includes high‐grade squamous intraepithelial lesion and ICC).
Conclusion
The present study suggests that initial screening with HPV E6/E7 mRNA testing rather than combined screening is a suitable candidate for cervical cancer screening in China (especially for premenopausal women) based on economic reasons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Affiliated Hospital of Jining Medical University, Jining, Shandong, China.
- Department of Gynecology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
ORCID-Profile: Linqing Yang
Förderung
- National Natural Science Foundation of China
- Shandong Province medical health science and technology project
- "Nursery" Scientific Research Program of Affiliated Hospital of Jining Medical University
Zitieren
APA
Liu, Y., Yang, S., Ma, Y., Gong, Y., Du, B., Wang, Y., & Yang, L. (2025). HPV E6 / E7 mRNA screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study. International Journal of Gynecology & Obstetrics, 169(1), 215-223. https://doi.org/10.1002/ijgo.16043
Vancouver
Liu Y, Yang S, Ma Y, Gong Y, Du B, Wang Y, et al. HPV E6 / E7 mRNA screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study. International Journal of Gynecology & Obstetrics. 2025;169(1):215-223. doi:10.1002/ijgo.16043
BibTeX
@article{Liu2025,
author = {Liu, Ying and Yang, Shirong and Ma, Yingying and Gong, Yingying and Du, Beibei and Wang, Yunfei and Yang, Linqing},
title = {HPV E6 / E7 mRNA screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
volume = {169},
number = {1},
pages = {215--223},
doi = {10.1002/ijgo.16043}
}
EUVIMED